Dr. David Kaplan, M.D

NPI: 1982661849
Total Payments
$826,358
2024 Payments
$26,044
Companies
51
Transactions
2,569

Payment Breakdown by Category

Other$558,266 (67.6%)
Consulting$111,442 (13.5%)
Travel$85,232 (10.3%)
Food & Beverage$48,399 (5.9%)
Research$21,735 (2.6%)
Education$1,275 (0.2%)
Gifts$10.12 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500,641 177 60.6%
Consulting Fee $111,442 37 13.5%
Travel and Lodging $85,232 265 10.3%
Honoraria $57,625 26 7.0%
Food and Beverage $48,399 1,945 5.9%
Unspecified $21,735 10 2.6%
Education $1,275 98 0.2%
Gift $10.12 11 0.0%

Payments by Type

General
$804,623
2,559 transactions
Research
$21,735
10 transactions

Top Paying Companies

Company Total Records Latest Year
Celgene Corporation $200,158 213 $0 (2019)
ABBVIE INC. $179,757 494 $0 (2024)
PFIZER INC. $151,629 286 $0 (2024)
Amgen Inc. $95,797 116 $0 (2024)
VYNE Pharmaceuticals Inc. $38,632 42 $0 (2021)
DERMIRA, INC. $38,038 54 $0 (2021)
GENZYME CORPORATION $34,609 49 $0 (2024)
Regeneron Healthcare Solutions, Inc. $19,964 76 $0 (2024)
E.R. Squibb & Sons, L.L.C. $15,580 76 $0 (2024)
Allergan Inc. $12,783 23 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $26,044 311 GENZYME CORPORATION ($17,370)
2023 $25,332 227 GENZYME CORPORATION ($14,740)
2022 $21,943 246 Amgen Inc. ($9,762)
2021 $60,372 244 Amgen Inc. ($43,655)
2020 $107,524 213 Amgen Inc. ($41,779)
2019 $255,787 445 Celgene Corporation ($119,413)
2018 $184,330 451 AbbVie, Inc. ($85,164)
2017 $145,028 432 AbbVie, Inc. ($71,009)

All Payment Transactions

2,569 individual payment records from CMS Open Payments — Page 1 of 103

Date Company Product Nature Form Amount Type
12/23/2024 Ortho Dermatologics, a division of Bausch Health US, LLC Cabtreo (Drug) Food and Beverage In-kind items and services $21.26 General
Category: Dermatology
12/19/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $21.24 General
12/19/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $8.67 General
Category: IMMUNOLOGY
12/19/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $5.33 General
Category: DERMATOLOGY
12/17/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $6.54 General
12/16/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $31.80 General
Category: Inflammation
12/12/2024 Arcutis Biotherapeutics, Inc. Zoryve (Drug) Food and Beverage In-kind items and services $17.47 General
Category: Dermatology
12/12/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $13.65 General
Category: IMMUNOLOGY
12/10/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $16.02 General
Category: Immunology
12/09/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $22.89 General
Category: Dermatology
12/05/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $28.84 General
Category: INFLAMMATION AND IMMUNOLOGY
12/05/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $15.69 General
Category: Immunology
12/05/2024 Almirall LLC Seysara (Drug) Food and Beverage In-kind items and services $6.41 General
Category: Dermatology
12/05/2024 Almirall LLC Seysara (Drug) Food and Beverage In-kind items and services $3.38 General
Category: Dermatology
12/04/2024 LEO Pharma Inc. ADBRY (Biological) Food and Beverage In-kind items and services $8.25 General
Category: DERMATOLOGY
12/03/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $77.98 General
Category: INFLAMMATION AND IMMUNOLOGY
12/03/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $29.03 General
12/03/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Food and Beverage In-kind items and services $19.11 General
Category: DERMATOLOGY
12/03/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $9.67 General
Category: DERMATOLOGY
11/27/2024 Ortho Dermatologics, a division of Bausch Health US, LLC Cabtreo (Drug) Food and Beverage In-kind items and services $16.23 General
Category: Dermatology
11/26/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $9.97 General
Category: Immunology
11/25/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $8.52 General
Category: DERMATOLOGY
11/21/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $28.96 General
Category: Inflammation
11/21/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $5.64 General
11/19/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $20.13 General

Research Studies & Clinical Trials

Study Name Company Amount Records
Truven PsA Manuscript Amgen Inc. $5,732 1
Truven TNF-IL PSO Manuscript - ClinicoEconomics and Outcomes Research Amgen Inc. $5,732 1
Biologic Initiation Risk in Systemic-Naive Psoriasis Patients with Comorbid Psoriatic Arthritis Sta Amgen Inc. $3,037 2
AMCP 2021 PCP vs Specialist Poster Amgen Inc. $2,694 1
AAD 2021 (VMX) Biologic Initiation Rates Poster Amgen Inc. $2,383 1
Biologic Initiation Rates AB - AAD 2021 Amgen Inc. $992.40 1
Real-world Health Outcomes in US Patients with Mild-to-Moderate Plaque Psoriasis Taking Topical The Amgen Inc. $814.58 1
Characterizing Outcomes and Unmet Needs among Patients in the US with Mild and Moderate Plaque Psori Amgen Inc. $285.71 1
Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals Amgen Inc. $64.64 1

About Dr. David Kaplan, M.D

Dr. David Kaplan, M.D is a Dermatology healthcare provider based in Overland Park, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982661849.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kaplan, M.D has received a total of $826,358 in payments from pharmaceutical and medical device companies, with $26,044 received in 2024. These payments were reported across 2,569 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($500,641).

Practice Information

  • Specialty Dermatology
  • Location Overland Park, KS
  • Active Since 04/26/2006
  • Last Updated 07/13/2022
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1982661849

Products in Payments

  • Otezla (Drug) $286,169
  • Humira (Biological) $150,692
  • EUCRISA (Drug) $150,411
  • DUPIXENT (Biological) $47,777
  • QBREXZA (Drug) $37,904
  • AMZEEQ (Drug) $27,033
  • ZILXI (Drug) $11,599
  • ACZONE (Drug) $7,786
  • OPZELURA (Drug) $7,470
  • Skyrizi (Biological) $5,232
  • ADBRY (Biological) $4,133
  • Cimzia (Drug) $3,760
  • SPEVIGO (Drug) $2,548
  • Bimzelx (Biological) $2,248
  • Sotyktu (Drug) $1,520
  • SKYRIZI (Biological) $1,501
  • VTAMA (Drug) $1,128
  • TREMFYA (Drug) $1,026
  • RINVOQ (Biological) $1,016
  • COSENTYX (Biological) $996.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Overland Park